Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms JPS016 |
Target |
Mechanism HDAC1 inhibitors(Histone deacetylase 1 inhibitors), HDAC2 inhibitors(Histone deacetylase 2 inhibitors), HDAC3 inhibitors(Histone deacetylase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC48H63N7O8S |
InChIKeyBOXZMOCGSKLDAH-OUZJXKGJSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 16 Mar 2022 |